Sparse high-dimensional linear mixed modeling with a partitioned empirical Bayes ECM algorithm

High-dimensional longitudinal data is increasingly used in a wide range of scientific studies. To properly account for dependence between longitudinal observations, statistical methods for high-dimensional linear mixed models (LMMs) have been developed. However, few packages implementing these high-...

Full description

Saved in:
Bibliographic Details
Published inStatistics and computing Vol. 35; no. 4
Main Authors Zgodic, Anja, Bai, Ray, Zhang, Jiajia, Olejua, Peter, McLain, Alexander C.
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Nature B.V 01.08.2025
Subjects
Online AccessGet full text
ISSN0960-3174
1573-1375
1573-1375
DOI10.1007/s11222-025-10649-z

Cover

More Information
Summary:High-dimensional longitudinal data is increasingly used in a wide range of scientific studies. To properly account for dependence between longitudinal observations, statistical methods for high-dimensional linear mixed models (LMMs) have been developed. However, few packages implementing these high-dimensional LMMs are available in the statistical software . Additionally, some packages suffer from scalability issues. This work presents an efficient and accurate Bayesian framework for high-dimensional LMMs. We use empirical Bayes estimators of hyperparameters for increased flexibility and an Expectation-Conditional-Minimization (ECM) algorithm for computationally efficient maximum a posteriori (MAP) estimation of parameters. The novelty of the approach lies in its partitioning and parameter expansion as well as its fast and scalable computation. We illustrate Linear Mixed Modeling with PaRtitiOned empirical Bayes ECM (LMM-PROBE) in simulation studies evaluating fixed and random effects estimation along with computation time. A real-world example is provided using data from a study of lupus in children with 15,424 genetic and clinical predictors. Whereas it is computationally prohibitive to fit other LMMs to this data, LMM-PROBE successfully identifies genes and clinical factors associated with a new lupus biomarker and predicts it over time. Supplementary materials are available online.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0960-3174
1573-1375
1573-1375
DOI:10.1007/s11222-025-10649-z